4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-20-023886
Chairman and CEO bought 13,000 shares at an average $1.25 ($16,235)
From the SEC's structured data for this filing
Trades in this filing
Niihara Yutaka · Chairman and CEO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-04-03 | Purchase : show line 1 in the form | +6,200 | $1.24 | $7,688 | 10,568,243 | D |
| 2020-04-06 | Purchase : show line 2 in the form | +4,700 | $1.26 | $5,922 | 10,572,943 | D |
| 2020-04-07 | Purchase : show line 3 in the form | +2,100 | $1.25 | $2,625 | 10,575,043 | D |
| Open-market purchases · 13,000 sh · avg $1.25 · $16,235 | ||||||
Loading xslF345X03/doc4.xml…